Overview
Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
Indication
Used in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy.
Associated Conditions
- Severe Migraine
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/07/16 | Not Applicable | Not yet recruiting | |||
2025/01/28 | Not Applicable | Recruiting | |||
2024/12/31 | N/A | Active, not recruiting | Damla Yürük | ||
2024/10/03 | Phase 4 | Recruiting | Institut Universitari D Investigacio En Atencion Primaria Jordi Gol | ||
2023/12/08 | Not Applicable | Not yet recruiting | Shalamar Institute of Health Sciences | ||
2023/12/01 | Phase 2 | Terminated | |||
2021/01/11 | Phase 4 | Recruiting | |||
2019/08/22 | Phase 4 | Completed | All India Institute of Medical Sciences, Bhubaneswar | ||
2018/10/19 | Not Applicable | Completed | |||
2016/04/22 | Phase 4 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| POLI-FLUNARIN CAPSULE 5 mg | SIN09449P | CAPSULE | 5 mg | 7/23/1997 | |
| FORKNOW TABLET 10 mg | SIN08250P | TABLET | 10 mg | 7/4/1995 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Flunarizine Hydrochloride Dispersible Tablets | 国药准字H20080275 | 化学药品 | 片剂 | 5/2/2023 | |
| Flunarizine Hydrochloride Oral Solution | 国药准字H20020094 | 化学药品 | 口服溶液剂 | 7/8/2020 | |
| Flunarizine Hydrochloride Tablets | 国药准字H20003604 | 化学药品 | 片剂 | 1/19/2020 | |
| Flunarizine Hydrochloride Tablets | 国药准字H19994105 | 化学药品 | 片剂 | 7/31/2020 | |
| Flunarizine Hydrochloride Tablets | 国药准字H20003610 | 化学药品 | 片剂 | 4/17/2020 | |
| Flunarizine Hydrochloride Tablets | 国药准字H20023105 | 化学药品 | 片剂 | 6/27/2019 | |
| Flunarizine Hydrochloride Tablets | 国药准字H19983108 | 化学药品 | 片剂 | 5/18/2020 | |
| Flunarizine Hydrochloride Tablets | 国药准字H10920064 | 化学药品 | 片剂 | 4/8/2020 | |
| Flunarizine Hydrochloride Tablets | 国药准字H19993527 | 化学药品 | 片剂 | 3/26/2020 | |
| Flunarizine Hydrochloride Tablets | 国药准字H20058081 | 化学药品 | 片剂 | 4/10/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| SIBERID-5 TAB 5MG | N/A | N/A | N/A | 8/27/1997 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.